David Efraim Rosen, 10% Owner at TherapeuticsMD, Inc. (TXMD), bought 565,000 shares at $4.72 ($2.7M) on 2022-07-29, disclosed to the SEC on 2022-08-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| TXMD | BUY | 2022-12-09 | $229K | — | Filing → |
| TXMD | BUY | 2022-07-19 | $935K | — | Filing → |
| RDUS | BUY | 2021-12-15 | $6.4M | — | Filing → |